Technical Analysis for MRNA - Moderna, Inc.

Grade Last Price % Change Price Change
grade F 14.05 -0.43% -0.06
MRNA closed down 0.43 percent on Monday, July 22, 2019, on 75 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
11 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Down Down
See historical MRNA trend table...

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Oversold Stochastic Weakness 0.00%
20 DMA Resistance Bearish -0.43%
Bollinger Band Squeeze Range Contraction -0.43%
Bollinger Band Squeeze Range Contraction -1.47%
Narrow Range Bar Range Contraction -1.47%
NR7 Range Contraction -1.47%
20 DMA Resistance Bearish 0.14%
Bollinger Band Squeeze Range Contraction 0.14%

Older signals for MRNA ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
Basic chart:
Profile
Moderna, Inc. develops medicines based on messenger RNA (mRNA). Its pipeline includes development candidates for mRNA-based vaccines and therapies for use in various therapeutic areas comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Cancer Life Sciences Biology RNA Messenger RNA
Is MRNA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Jul 16 4 ‘Strong Buy’ Biotechs With Big 3Q19 Catalysts
Jul 10 Moderna to Present at ROTH RNA Revolution Conference
Jul 9 Here's Why Moderna Lost 29.6% in June
Jul 8 The Science Of Biotech Investing With Bhavneesh Sharma (Podcast)
Jun 28 Top 10 Most Oversold Stocks Via Benzinga Pro's Radar Tool For Friday, June 28, 2019
Jun 25 Is Moderna, Inc. (MRNA) A Good Stock To Buy?
Jun 22 Stocks To Watch: Nike, FedEx And Bank Stress Tests
Jun 18 Moderna to Present at BMO 2019 Prescriptions for Success Healthcare Conference
Jun 11 Moderna, Inc. (NASDAQ:MRNA): Financial Strength Analysis
Jun 7 Moderna to Present at Goldman Sachs 40th Annual Global Healthcare Conference
See more MRNA news...
Indicators
Indicator Value
52 Week High 29.79
52 Week Low 13.03
Average Volume 1,404,300
200-Day Moving Average 0.0
50-Day Moving Average 17.4938
20-Day Moving Average 14.354
10-Day Moving Average 14.29
Average True Range 0.7285
ADX 29.39
+DI 14.6375
-DI 22.1695
Chandelier Exit (Long, 3 ATRs ) 13.7495
Chandelier Exit (Short, 3 ATRs ) 15.6855
Upper Bollinger Band 15.1258
Lower Bollinger Band 13.5822
Percent B (%b) 0.3
BandWidth 10.753797
MACD Line -0.8471
MACD Signal Line -1.0442
MACD Histogram 0.1971
Fundamentals Value
Market Cap 128.36 Million
Num Shares 9.14 Million
EPS -3.84
Price-to-Earnings (P/E) Ratio -3.66
Price-to-Sales 4.85
Price-to-Book 0.47
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.67
Resistance 3 (R3) 14.69 14.50 14.56
Resistance 2 (R2) 14.50 14.35 14.49 14.53
Resistance 1 (R1) 14.28 14.25 14.19 14.26 14.49
Pivot Point 14.09 14.09 14.05 14.08 14.09
Support 1 (S1) 13.87 13.94 13.78 13.85 13.61
Support 2 (S2) 13.68 13.84 13.67 13.57
Support 3 (S3) 13.46 13.68 13.54
Support 4 (S4) 13.44